Ronny L. Jackson, MD, would give up $1 million in retirement income to head the Department of Veterans Affairs and work in the Trump administration; mega healthcare deals endanger independent practices of primary care providers; Novartis is buying a gene therapy firm focused on spinal muscular atrophy.
The nomination of President Donald Trump’s doctor, Ronny L. Jackson, MD, to head the Department of Veterans Affairs has grown more complicated by the Navy physician’s pending military promotion, The Washington Post reported. If confirmed for the Cabinet post, he would be forced to give up an estimated $1 million in future retirement income. The dual nominations and a lack of clarity from the White House have left lawmakers confused about how to proceed.
New mega-mergers as well as an increasing propensity for patients to head to urgent care centers or retail clinics is putting pressure on independent primary care doctors, The New York Times reported over the weekend. One example: Walmart and Humana. One potential partnership under consideration would focus on using the retailer’s stores and expanding its existing 19 clinics for 1-stop medical care. In addition, the proposed $69 billion merger between CVS Health, which operates 1100 MinuteClinics, and Aetna, the giant insurer, would expand the customer bases of both. And rival UnitedHealth Group employs more than 30,000 physicians and operates one of the largest urgent-care groups, MedExpress, as well as a big chain of free-standing surgery centers.
Novartis is buying gene therapy company AveXis for $8.7 billion, The Wall Street Journal reported. AveXis is a gene therapy company conducting several clinical studies for the treatment of spinal muscular atrophy. Novartis is betting that at least 1 promising drug that AveXis is developing will translate into a blockbuster. Novartis has already spearheaded gene therapy in oncology.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More